Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report mTOR inhibitors, AAV gene therapy, ganaxolone, and ASO strategies shaping the TSC drug pipeline. A patent-intelligence analysis by PatSnap Insights.
Article | Report How SOD1 ASOs, TDP-43 splice-switch oligonucleotides, anti-TDP-43 antibodies, and neurofilament biomarkers are reshaping the ALS drug pipeline. Patent intelligence analysis.
Article | Report How does microfluidic chip-based cell sorting compare to FACS for CAR-T therapy? Patent data reveals a 100x sensitivity gain and closed-system sterility advantages.
Article | Report Analyse the progressive MS drug pipeline: BTK inhibitors, remyelination strategies, and neuroprotection approaches. Patent intelligence from PatSnap Eureka.
Article | Report How XAI mechanisms help clinical decision support systems meet EU AI Act transparency, auditability, and compliance requirements. Patent analysis from 8 key filings.
Article | Report VMAT2 inhibitors dominate the tardive dyskinesia drug pipeline. Explore patent landscape analysis of valbenazine, deutetrabenazine, PDE7/PDE10 inhibitors, and emerging gene therapy approaches.
Article | Report How closed-loop quality control, fracture-mechanics thresholds, and inter-process correlation enable zero-defect manufacturing in high-volume automotive stamping.
Article | Report Explore next-generation smoking cessation drugs: nicotinic receptor partial agonists, 5-HT2C agonists, anti-nicotine antibodies, cannabinoids, and botanical approaches in the patent pipeline.
Article | Report Explore the knee osteoarthritis drug pipeline: GLP-1 agonists, dual IL-1α/β blockade, NLRP3 inhibitors, and intraarticular delivery platforms from Novartis, AbbVie, INSERM and more.
Article | Report How do engineers reduce oxidation-induced embrittlement in refractory high-entropy alloys for hypersonic thermal protection? Patent evidence, coating strategies, and design principles explained.
Article | Report How can engineers reduce oxidation-induced embrittlement in refractory high-entropy alloys for hypersonic thermal protection? Patent-backed strategies analysed.
Article | Report How do open rotor engines compare to geared turbofan for short-haul decarbonization? Bypass ratios, TSFC data, noise trade-offs, and hybrid pathways analysed.
Article | Report How RNAi, ASO, and GalNAc-siRNA approaches target angiotensinogen (AGT) to treat resistant hypertension — patent landscape, clinical signals, and key findings.
Article | Report How do open rotor engines compare to geared turbofans for short-haul decarbonization? Bypass ratios, TSFC data, noise trade-offs, and hybrid-electric pathways analysed.
Article | Report How to validate AI perception systems under ISO 21448 SOTIF for highway pilot: patent intelligence on XAI, sensor fusion, residual risk, and scenario testing.